MICAL1 - microtubule associated monooxygenase, calponin and LIM domain containing 1 Gene
Species: Macaca fascicularis
Gene Type: protein coding
Gene ID: 102139619
MICAL1 Products (5)
| mRNA | Protein | Name |
|---|---|---|
| XM_015448550.2 | XP_015304036.2 | F-actin-monooxygenase MICAL1 isoform X1 |
| XM_015448553.2 | XP_015304039.2 | F-actin-monooxygenase MICAL1 isoform X1 |
| XM_015448549.2 | XP_015304035.2 | F-actin-monooxygenase MICAL1 isoform X1 |
| XM_015448554.2 | XP_015304040.2 | F-actin-monooxygenase MICAL1 isoform X2 |
| XM_015448551.2 | XP_015304037.2 | F-actin-monooxygenase MICAL1 isoform X1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
F-actin-monooxygenase MICAL1 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(31)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B2176 | ATP | 99.88% | Unkown | |
| HY-12678 | Entrectinib | 99.26% | Yes | |
| HY-13757 | Tamoxifen Citrate | 99.88% | Yes | |
| HY-109506 | DPPC | 99.91% | Unkown | |
| HY-109044 | Tapinarof | Agonist | 99.95% | Unkown |
| HY-B1192 | Estradiol benzoate | Agonist | 99.90% | Unkown |
| HY-B0448 | Phenytoin | Inhibitor | 99.95% | Yes |
| HY-B1005 | 8-Hydroxyquinoline | Inhibitor | 99.99% | Unkown |
| HY-B0892 | Benzyl alcohol | 99.99% | Unkown | |
| HY-B0693 | Ranitidine | Antagonist | 99.9% | Yes |
| HY-B0448A | Phenytoin sodium | Inhibitor | 99.78% | Yes |
| HY-B0111 | Drospirenone | Agonist | 99.95% | Unkown |
| HY-124290 | Carotegrast methyl | Antagonist | 99.24% | Unkown |
| HY-B0344 | Methscopolamine bromide | Inhibitor | 99.81% | Unkown |
| HY-B1198 | Piperonyl butoxide | Inhibitor | 98.0% | Unkown |
| HY-B0281A | Ranitidine hydrochloride | Antagonist | 99.86% | Yes |
| HY-B0417A | Lincomycin hydrochloride | Inhibitor | 99.59% | Unkown |
| HY-B1350A | Fusidic acid sodium salt | Inhibitor | 99.64% | Yes |
| HY-B1358 | Lincomycin hydrochloride monohydrate | Inhibitor | 99.74% | Unkown |
| HY-B1640R | Ethacrynic acid (Standard) | Inhibitor | 98.78% | Unkown |
| HY-117660 | Lincomycin | Inhibitor | 99.82% | Unkown |
| HY-13859 | Clevudine | Inhibitor | 99.84% | Unkown |
| HY-B1268 | Docusate Sodium | Inhibitor | 98.0% | Unkown |
| HY-P0009 | Cetrorelix | Antagonist | 99.71% | Yes |
| HY-12752A | Alimemazine hemitartrate | 99.49% | Unkown | |
| HY-B0921 | Succinylsulfathiazole | Inhibitor | 99.22% | Unkown |
| HY-B0693A | Ranitidine bismuth citrate | / | Unkown | |
| HY-B1198R | Piperonyl butoxide (Standard) | Inhibitor | / | Unkown |
| HY-B1640A | Ethacrynic acid sodium | Inhibitor | / | Unkown |
| HY-133171A | (S)-Norfluoxetine | Inhibitor | / | Unkown |
| HY-B0430B | (±)-Pantothenic acid | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P9944 | Palivizumab | Inhibitor | 99.63% | Unkown |
| HY-P99797 | Pabinafusp alfa | 98.89% | Unkown |
Clinical Phase
Bioactive Molecules
(27)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-B1946 | Dimethoate | 99.91% | Phase 4 | |
| HY-N6869 | Dehydroabietic acid | 98.52% | Phase 4 | |
| HY-163885 | SSZ | Inhibitor | 98.13% | Phase 4 |
| HY-70062 | Pevonedistat | 99.98% | Phase 3 | |
| HY-10484 | Pevonedistat hydrochloride | 99.19% | Phase 3 | |
| HY-145721A | Mongersen sodium | 99.61% | Phase 3 | |
| HY-145721 | Mongersen | Inhibitor | 98.57% | Phase 3 |
| HY-100442 | Paquinimod | Inhibitor | 99.90% | Phase 2 |
| HY-10367 | Canertinib | Inhibitor | 99.74% | Phase 2 |
| HY-141523 | Vociprotafib | Inhibitor | 99.70% | Phase 2 |
| HY-14530 | Pelitrexol | 98.07% | Phase 2 | |
| HY-129239 | Farudodstat | 99.68% | Phase 2 | |
| HY-123475 | Sisunatovir | Inhibitor | 99.40% | Phase 2 |
| HY-10367A | Canertinib dihydrochloride | Inhibitor | 99.68% | Phase 2 |
| HY-18099 | S1RA | Antagonist | 98.96% | Phase 2 |
| HY-137440 | Firazorexton | 99.56% | Phase 2 | |
| HY-148100 | Emapticap pegol | Inhibitor | 91.38% | Phase 2 |
| HY-137440A | Firazorexton hydrate | 99.94% | Phase 2 | |
| HY-14866 | Raseglurant | Modulator | 99.65% | Phase 2 |
| HY-106887 | SCH 32615 | 99.68% | Phase 2 | |
| HY-168739 | Topoisomerase I inhibitor 17 | / | Phase 2 | |
| HY-116175 | BIBB 515 | 99.56% | Phase 1 | |
| HY-125639 | (rac)-AR-13503 | Inhibitor | 99.08% | Phase 1 |
| HY-115681 | (2R/S)-6-PNG | Inhibitor | 99.96% | Phase 1 |
| HY-111792 | GSK1795091 | Agonist | 94.48% | Phase 1 |
| HY-106925 | Cetefloxacin | Inhibitor | / | Phase 1 |
| HY-117630 | RB-6145 | / | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P9983 | Lintuzumab | Inhibitor | 98.09% | Phase 3 |
| HY-P99744 | Modakafusp alfa | Inhibitor | 96.22% | Phase 2 |
| HY-P991961 | REGN4659 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(540)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-14452 | Fatostatin | Inhibitor | 99.85% | Unkown |
| HY-N0219 | Bicuculline | Antagonist | 99.98% | Unkown |
| HY-134901 | WM-3835 | 99.78% | Unkown | |
| HY-160769 | NIBR-LTSi | 99.97% | Unkown | |
| HY-131042 | NNMTi | Inhibitor | 99.70% | Unkown |
| HY-110171 | iMDK | Inhibitor | 99.35% | Unkown |
| HY-113354 | Anserine | 99.85% | Unkown | |
| HY-160818 | MC3138 | Activator | 99.92% | Unkown |
| HY-N2342 | Procyanidin C1 | Inducer | 99.54% | Unkown |
| HY-120912 | Gingerenone A | Activator | 99.95% | Unkown |
| HY-103124 | DOI hydrochloride | Agonist | 99.61% | Unkown |
| HY-14452A | Fatostatin hydrobromide | Inhibitor | 99.52% | Unkown |
| HY-143228 | SH-42 | Inhibitor | 99.87% | Unkown |
| HY-103157 | PD146176 | 99.59% | Unkown | |
| HY-156856 | FL118-14-Propanol | 99.56% | Unkown | |
| HY-135747 | Gut restricted-7 | Inhibitor | 99.54% | Unkown |
| HY-126255 | SBI-797812 | Activator | 99.88% | Unkown |
| HY-P1925A | GO-203 TFA | 98.39% | Unkown | |
| HY-137207 | MK-28 | Activator | 99.88% | Unkown |
| HY-103017A | JH-X-119-01 | Inhibitor | 99.65% | Unkown |
| HY-114169 | WRG-28 | Inhibitor | 99.76% | Unkown |
| HY-131181 | LEI-401 | Inhibitor | 99.73% | Unkown |
| HY-161834 | RG100204 | Inhibitor | 99.50% | Unkown |
| HY-113365 | Cholestenone | 99.95% | Unkown | |
| HY-125474 | Carrageenan | Inhibitor | / | Unkown |
| HY-108559 | L-161982 | Inhibitor | 99.33% | Unkown |
| HY-117427 | D5D-IN-326 | 99.90% | Unkown | |
| HY-P1587 | IRBP (1-20), human | 99.58% | Unkown | |
| HY-134494 | MS48107 | 99.90% | Unkown | |
| HY-156117 | LB244 | Inhibitor | 98.45% | Unkown |
| HY-124284 | Hexamethylene bisacetamide | 99.56% | Unkown | |
| HY-111754 | DMX-5804 | Inhibitor | 99.83% | Unkown |
| HY-W010042 | L-Glucose | 99.90% | Unkown | |
| HY-110171A | iMDK quarterhydrate | Inhibitor | 99.37% | Unkown |
| HY-N8522 | 9,10-Dihydroxystearic acid | 98.0% | Unkown | |
| HY-P1290A | PKA Inhibitor Fragment (6-22) amide TFA | Inhibitor | 99.77% | Unkown |
| HY-P1136C | TAT-Gap19 TFA | 99.41% | Unkown | |
| HY-103111 | MMPIP hydrochloride | Antagonist | 99.10% | Unkown |
| HY-101404A | L-Homocysteine thiolactone hydrochloride | 99.99% | Unkown | |
| HY-103400 | 8-Chloroadenosine | 99.75% | Unkown | |
| HY-147323 | Ferulic acid 4-O-sulfate | 98.86% | Unkown | |
| HY-160023 | Elisrasib | 98.50% | Unkown | |
| HY-110190 | VU0422288 | Modulator | 99.94% | Unkown |
| HY-N1388 | Tussilagone | 99.52% | Unkown | |
| HY-P1136B | TAT-Gap19 | 99.60% | Unkown | |
| HY-120597 | SAK3 | Activator | 99.80% | Unkown |
| HY-121675 | 2-Bromo-LSD | 97.26% | Unkown | |
| HY-B0708 | β-Estradiol 17-acetate | Agonist | 99.93% | Unkown |
| HY-W013411A | Locostatin | 99.88% | Unkown | |
| HY-129297 | CMPF | 99.64% | Unkown | |
| HY-19350 | BML-210 | 98.04% | Unkown | |
| HY-B1002 | Oxolinic acid | Inhibitor | 98.97% | Unkown |
| HY-W015635 | Diallyl disulfide | Inhibitor | 99.8% | Unkown |
| HY-B2176I | ATP disodium salt, 100 mM Solution, PCR Grade | / | Unkown | |
| HY-101029 | MBM-55 | 99.94% | Unkown | |
| HY-127034 | Antipain dihydrochloride | Inhibitor | 99.9% | Unkown |
| HY-N2189 | Swertisin | 99.54% | Unkown | |
| HY-125130 | Hesperetin 7-O-glucoside | Inhibitor | 99.38% | Unkown |
| HY-114918 | MS438 | Agonist | 99.85% | Unkown |
| HY-171034 | PQA-18 | Inhibitor | 99.62% | Unkown |
| HY-103017 | JH-X-119-01 hydrochloride | Inhibitor | 99.14% | Unkown |
| HY-161305 | SE-7552 | Inhibitor | 99.48% | Unkown |
| HY-119347 | Cirsilineol | Inhibitor | 98.0% | Unkown |
| HY-113412A | 3-Methylhistamine dihydrochloride | 99.80% | Unkown | |
| HY-145313 | TTBK1-IN-2 | Inhibitor | 99.91% | Unkown |
| HY-15805 | KIN-8194 | Inhibitor | 99.26% | Unkown |
| HY-N5106 | (E)-Flavokawain A | Inducer | 99.53% | Unkown |
| HY-W018171 | 3,5,6-Trichloro-2-pyridinol | 99.85% | Unkown | |
| HY-155157 | PF-07247685 | Inhibitor | 98.66% | Unkown |
| HY-N7271 | Solanidine | 99.90% | Unkown | |
| HY-156856S | FL118-14-Propanol-d5 | 97.86% | Unkown | |
| HY-N1109 | Uvaol | Inducer | 99.20% | Unkown |
| HY-P2203 | SAHM1 | Inhibitor | 96.48% | Unkown |
| HY-116538 | (10E,12Z)-Octadeca-10,12-dienoic acid | Activator | 99.10% | Unkown |
| HY-N10991 | Crocetin dialdehyde | 99.75% | Unkown | |
| HY-111358 | TLR7 agonist 1 | Agonist | 98.19% | Unkown |
| HY-103290 | R715 | Antagonist | 99.67% | Unkown |
| HY-107527 | Org 25543 hydrochloride | Inhibitor | 99.93% | Unkown |
| HY-163087 | PT-91 | Agonist | 98.78% | Unkown |
| HY-N0506 | Rosarin | 99.96% | Unkown | |
| HY-N6962 | α-Spinasterol | 99.90% | Unkown | |
| HY-164546 | WB436B | 99.93% | Unkown | |
| HY-101139A | Xanthine amine congener hydrochloride | Antagonist | 98.03% | Unkown |
| HY-108497 | L-803087 | Agonist | 99.66% | Unkown |
| HY-21196A | Potassium perfluorohexanesulfonate | 98.0% | Unkown | |
| HY-B2046 | Simazine | 99.44% | Unkown | |
| HY-N2736 | 3′,4′,7-Trihydroxyflavone | Inhibitor | 99.04% | Unkown |
| HY-N0901A | Corynoxine B | Inhibitor | 99.76% | Unkown |
| HY-B0448S | Phenytoin-d10 | Inhibitor | 99.50% | Unkown |
| HY-116818 | Crebinostat | Inhibitor | 98.83% | Unkown |
| HY-120589 | VU0360172 | Agonist | 98.07% | Unkown |
| HY-121035 | 7BIO | Inhibitor | 99.20% | Unkown |
| HY-12242 | GBR 12935 dihydrochloride | Inhibitor | 99.80% | Unkown |
| HY-143793 | RBP4 inhibitor 1 | Inhibitor | 99.49% | Unkown |
| HY-21193 | Perfluoropentanoic acid | 98.0% | Unkown | |
| HY-P10032 | NN1177 | 99.54% | Unkown | |
| HY-P1259A | PR-39 TFA | Inhibitor | 99.89% | Unkown |
| HY-Y0850U6 | PVA (Mw 205000) | / | Unkown | |
| HY-Y1809 | 1-Hydroxyoctadecane | 99.65% | Unkown | |
| HY-132302 | Hu7691 | Inhibitor | 99.91% | Unkown |
| HY-147222 | SAE-14 | Antagonist | 98.60% | Unkown |
| HY-155478 | Androgen receptor-IN-6 | Inhibitor | 98.26% | Unkown |
| HY-160237 | HYL001 | Inhibitor | 99.94% | Unkown |
| HY-164495 | Sob-AM2 | Agonist | 98.5% | Unkown |
| HY-P3102 | GLP-1(32-36)amide | 98.44% | Unkown | |
| HY-148506 | 5'-ODMT cEt m5U Phosphoramidite (Amidite) | 99.76% | Unkown | |
| HY-149449 | Poly-L-γ-glutamic acid sodium | / | Unkown | |
| HY-145774 | PD-1/PD-L1-IN-23 | Inhibitor | 99.98% | Unkown |
| HY-118282 | mPGES1-IN-7 | Inhibitor | 99.78% | Unkown |
| HY-12678S1 | Entrectinib-d8 | 99.82% | Unkown | |
| HY-136182 | YM-244769 dihydrochloride | Inhibitor | 98.57% | Unkown |
| HY-136182A | YM-244769 | Inhibitor | 99.22% | Unkown |
| HY-139659 | ARD-61 | 99.57% | Unkown | |
| HY-156374 | D359-0396 | Inhibitor | 99.98% | Unkown |
| HY-161671 | GAT2711 | Agonist | 98.00% | Unkown |
| HY-162387 | UK4b | Inhibitor | 96.17% | Unkown |
| HY-162428 | PTPN2/1-IN-3 | Inhibitor | 99.89% | Unkown |
| HY-163782 | SMIP-031 | 98.60% | Unkown | |
| HY-N2411 | Geissoschizine methyl ether | Agonist | 99.97% | Unkown |
| HY-N3522 | Platycoside E | Inhibitor | 99.40% | Unkown |
| HY-P1302 | Orphanin FQ(1-11) | Agonist | 99.83% | Unkown |
| HY-W248594 | IR 813 tosylate | 98.52% | Unkown | |
| HY-W674241 | 4-Ethylphenyl sulfate | Inducer | / | Unkown |
| HY-113354S | Anserine-d4 | 99.38% | Unkown | |
| HY-B1946S | Dimethoate-d6 | 99.86% | Unkown | |
| HY-P5489 | IGRP(206-214) | Agonist | 96.63% | Unkown |
| HY-120000 | MS402 | Inhibitor | 98.36% | Unkown |
| HY-123475A | Sisunatovir hydrochloride | Inhibitor | 98.61% | Unkown |
| HY-100935 | Cimaterol | Agonist | 99.13% | Unkown |
| HY-118824A | N-Feruloylserotonin | Inhibitor | 99.93% | Unkown |
| HY-121852 | SCH 336 | Agonist | 98.63% | Unkown |
| HY-143312E | (S)-V-0219 hydrochloride | Modulator | 99.71% | Unkown |
| HY-144899 | ASR-490 | Inhibitor | 99.20% | Unkown |
| HY-162866 | CXM102 | Activator | 99.36% | Unkown |
| HY-D0887 | Disodium 5'-inosinate | 99.74% | Unkown | |
| HY-N1503 | Methyl deacetylasperulosidate | 98.49% | Unkown | |
| HY-120083 | Rodatristat | Inhibitor | 98.41% | Unkown |
| HY-172930 | PVTX-405 | / | Unkown | |
| HY-126193 | JS-K | 99.59% | Unkown | |
| HY-126367 | Light green SF yellowish | 75.0% | Unkown | |
| HY-139973 | OAB-14 | 99.21% | Unkown | |
| HY-163729 | I-BET787 | Inhibitor | 99.88% | Unkown |
| HY-164397 | XMU-MP-5 | 99.00% | Unkown | |
| HY-173313 | Ferroptosis-IN-19 | Inhibitor | 98.92% | Unkown |
| HY-174400 | SGLT2-IN-2 | Inhibitor | 99.57% | Unkown |
| HY-N6579 | Arvenin I | 89.41% | Unkown | |
| HY-N7026 | Celosin I | 99.91% | Unkown | |
| HY-N9173 | Cupressuflavone | 99.32% | Unkown | |
| HY-P10032A | NN1177 TFA | 99.22% | Unkown | |
| HY-P10816 | PACE4 Inhibitory peptide C23 | 99.40% | Unkown | |
| HY-114853 | BVT.13 | Agonist | 98.44% | Unkown |
| HY-114992 | 2-Propyl-2-pentenoic acid | 95.0% | Unkown | |
| HY-160554 | C12-113 | 98.67% | Unkown | |
| HY-B1870 | Metaldehyde | 98.0% | Unkown | |
| HY-136522 | S2116 | 98.05% | Unkown | |
| HY-B1198S | Piperonyl butoxide-d9 | Inhibitor | 98.68% | Unkown |
| HY-100442S1 | Paquinimod-d5-1 | Inhibitor | 98.19% | Unkown |
| HY-106947 | SY-640 | 99.77% | Unkown | |
| HY-107503 | MMPIP | Antagonist | 99.38% | Unkown |
| HY-117081 | C30(ω-hydroxy) Ceramide (d18:1/30:0) | 99.46% | Unkown | |
| HY-121675A | 2-Bromo-LSD D-Tartrate | 99.91% | Unkown | |
| HY-124609 | CAD031 | 99.39% | Unkown | |
| HY-129087 | BC-1258 | Inducer | 99.85% | Unkown |
| HY-130136A | TMPRSS6-IN-1 TFA | Inhibitor | / | Unkown |
| HY-155156 | PF-07238025 | Inhibitor | 99.46% | Unkown |
| HY-156277 | SP4f | Activator | 99.77% | Unkown |
| HY-156842 | MCAAD-3 | 98.19% | Unkown | |
| HY-157014 | TPT-004 | Inhibitor | 99.90% | Unkown |
| HY-161853 | TX-2552 | Inhibitor | 99.69% | Unkown |
| HY-162702 | AZ'3137 | Degrader | 99.90% | Unkown |
| HY-169240 | MX69-102 | Activator | 99.44% | Unkown |
| HY-173267 | CES2A-IN-2 | Inhibitor | 99.16% | Unkown |
| HY-N9794 | Isoboldine | 95.0% | Unkown | |
| HY-P1949A | Cyclic MKEY TFA | 98.47% | Unkown | |
| HY-W009688 | Dibutyl maleate | 99.19% | Unkown | |
| HY-W012837 | Benzylmethyl ether | Inhibitor | 98.70% | Unkown |
| HY-W013755 | Dioctyl phthalate | 99.40% | Unkown | |
| HY-101030A | MBM-17S | / | Unkown | |
| HY-120872 | AJS1669 free acid | Activator | 99.15% | Unkown |
| HY-153262 | (7R)-Elisrasib | Inhibitor | 99.52% | Unkown |
| HY-103177 | PSB-10 hydrochloride | Inhibitor | / | Unkown |
| HY-103327 | MJ15 | Antagonist | / | Unkown |
| HY-107504 | VU0360172 hydrochloride | Agonist | 98.94% | Unkown |
| HY-107659 | YM-244769 hydrochloride | Inhibitor | 98.09% | Unkown |
| HY-112636 | Astrophloxine | Inhibitor | 98.34% | Unkown |
| HY-113878 | 12-OAHSA | 99.0% | Unkown | |
| HY-120514 | JNc-440 | 98.04% | Unkown | |
| HY-121271 | Kadsurin | 99.38% | Unkown | |
| HY-122817 | FR900098 sodium | Inhibitor | 99.77% | Unkown |
| HY-126152 | Chlorthiamid | 95.69% | Unkown | |
| HY-12678S | Entrectinib-d4 | Inhibitor | / | Unkown |
| HY-130136 | TMPRSS6-IN-1 | Inhibitor | / | Unkown |
| HY-151876 | Glucocorticoid receptor modulator 1 | 99.79% | Unkown | |
| HY-156276 | SP4e | Activator | 99.72% | Unkown |
| HY-156936 | RCB-02-4-8 | 99.3% | Unkown | |
| HY-159972 | PKR1 antagonist 1 | Antagonist | / | Unkown |
| HY-160550 | DPM-1003 | Inhibitor | / | Unkown |
| HY-161901 | BC-1293 | Inhibitor | 98.40% | Unkown |
| HY-162765 | TRPV4-IN-5 | Inhibitor | 98.77% | Unkown |
| HY-167862A | UCM-05194 ammonium | Agonist | / | Unkown |
| HY-179474 | TSI-13-57 | Inhibitor | 98.73% | Unkown |
| HY-18164 | TASP0277308 | Antagonist | 99.00% | Unkown |
| HY-19015 | Probimane | Inhibitor | 99.91% | Unkown |
| HY-B1002R | Oxolinic acid (Standard) | Inhibitor | 97.60% | Unkown |
| HY-D1056A5 | Lipopolysaccharides, from E. coli K-235 | Activator | / | Unkown |
| HY-D1065 | NIR-H2O2 | / | Unkown | |
| HY-N3204 | Neoechinulin A | Inhibitor | 98.0% | Unkown |
| HY-N5097 | 13-Oxo-9E,11E-octadecadienoic acid | Activator | / | Unkown |
| HY-N7514 | Strictosidinic acid | Inhibitor | 95% | Unkown |
| HY-P11060 | MC38 SLP Adpgk | 97.52% | Unkown | |
| HY-P5117 | TAT-CIRP | Inhibitor | 98.32% | Unkown |
| HY-P5890A | YVAD-CHO TFA | Inhibitor | 98.48% | Unkown |
| HY-W013411 | (E/Z)-Locostatin | Control | 99.52% | Unkown |
| HY-W674241A | 4-Ethylphenyl sulfate sodium | Inducer | / | Unkown |
| HY-12242A | GBR 12935 | Inhibitor | / | Unkown |
| HY-138289 | 4-acetoxy MPT | 98.8% | Unkown | |
| HY-165014 | 2C-I-FLY hydrochloride | 99.3% | Unkown | |
| HY-169858 | Prostaglandin E2 Inhibitor 3 | Inhibitor | 99.2% | Unkown |
| HY-20874 | Deschlorodemethyldiazepam | 99.80% | Unkown | |
| HY-70062R | Pevonedistat (Standard) | 99.51% | Unkown | |
| HY-N16039 | TAN-1030A | Activator | / | Unkown |
| HY-101029A | MBM-55S | / | Unkown | |
| HY-101030 | MBM-17 | / | Unkown | |
| HY-120667 | DS-5272 | / | Unkown | |
| HY-12459 | Pyrindamycin B | Inhibitor | / | Unkown |
| HY-132302A | Hu7691 free base | Inhibitor | / | Unkown |
| HY-139798 | Iboxamycin | Inhibitor | / | Unkown |
| HY-100782 | DL-AP7 | Antagonist | / | Unkown |
| HY-10084 | CK0106023 | Inhibitor | / | Unkown |
| HY-100922 | N-Acetylglycyl-D-glutamic acid | Agonist | / | Unkown |
| HY-10109A | AS-605240 potassium | Inhibitor | / | Unkown |
| HY-101384 | Ro 10-5824 | Agonist | / | Unkown |
| HY-101699 | AMG-076 free base | Antagonist | / | Unkown |
| HY-101780A | Tinostamustine hydrochloride | Inhibitor | / | Unkown |
| HY-103357 | LY288513 | Antagonist | / | Unkown |
| HY-103567 | Desmethyl-YM-298198 hydrochloride | Antagonist | / | Unkown |
| HY-105052 | SC 34301 | / | Unkown | |
| HY-105236 | (Rac)-Enadoline | Agonist | / | Unkown |
| HY-105969 | Dichloromethotrexate | / | Unkown | |
| HY-106752 | CI-936 | Agonist | / | Unkown |
| HY-106837 | Israpafant | Antagonist | / | Unkown |
| HY-108497A | L-803087 TFA | Agonist | / | Unkown |
| HY-108538 | Ethacrynic acid D5 | Inhibitor | / | Unkown |
| HY-110020 | rel-O-2050 | Antagonist | / | Unkown |
| HY-111315 | XEN103 | Inhibitor | / | Unkown |
| HY-113354S1 | Anserine-d4 hydrochloride | / | Unkown | |
| HY-113866 | E-55888 | Agonist | / | Unkown |
| HY-113889 | ZK112993 | Antagonist | / | Unkown |
| HY-114542 | LY 201409 | / | Unkown | |
| HY-114651 | Phenazoviridin | / | Unkown | |
| HY-116046 | GR 196429 | Agonist | / | Unkown |
| HY-116597 | L-783483 | Agonist | / | Unkown |
| HY-117555 | 4010B-30 | Activator | / | Unkown |
| HY-117569 | KF24345 free base | Inhibitor | / | Unkown |
| HY-117603 | CM-10-18 | Inhibitor | / | Unkown |
| HY-117660S1 | Lincomycin-13C,d3 | Inhibitor | / | Unkown |
| HY-117836 | FAK-IN-16 | Inhibitor | / | Unkown |
| HY-118030 | RQ-00311651 | Antagonist | / | Unkown |
| HY-118032 | Bozepinib | / | Unkown | |
| HY-118426 | (Rac)-Tipifarnib | Inhibitor | / | Unkown |
| HY-118574 | UBP141 | Antagonist | / | Unkown |
| HY-118626 | PD-254552 | Inhibitor | / | Unkown |
| HY-119519 | OB-2 | Inhibitor | / | Unkown |
| HY-119899 | BO-0742 | / | Unkown | |
| HY-120171 | DH-376 | Inhibitor | / | Unkown |
| HY-120225 | NJK14047 | Inhibitor | / | Unkown |
| HY-120561 | PC-046 | / | Unkown | |
| HY-120769 | Pimprinine | Inhibitor | ≥90.0% | Unkown |
| HY-120804 | PH-46A | Inhibitor | / | Unkown |
| HY-121431 | FR-901235 | / | Unkown | |
| HY-12153 | JNJ-1930942 | Modulator | / | Unkown |
| HY-121565 | SaRI 59-801 | Activator | / | Unkown |
| HY-122179 | NUCC-555 | Antagonist | / | Unkown |
| HY-122309 | A-71497 | / | Unkown | |
| HY-122518 | 8-Deazafolic acid | Inhibitor | / | Unkown |
| HY-122655 | HMCEF | Inhibitor | / | Unkown |
| HY-122916 | 7-Acetyllycopsamine | / | Unkown | |
| HY-123020 | CYD-2-88 | Antagonist | / | Unkown |
| HY-123237 | KRC-108 | / | Unkown | |
| HY-123357 | IMM-H004 | Inhibitor | / | Unkown |
| HY-124412S | Paynantheine-d3 | / | Unkown | |
| HY-124557 | Mahanimbine | Inhibitor | / | Unkown |
| HY-126185 | Nibroxane | Inhibitor | / | Unkown |
| HY-126835 | A924 | / | Unkown | |
| HY-126910 | Mesyl Salvinorin B | Agonist | / | Unkown |
| HY-127039 | Antipain | Inhibitor | / | Unkown |
| HY-129335 | Chlorozotocin | Inhibitor | / | Unkown |
| HY-129406 | AF 698 | / | Unkown | |
| HY-129577 | Aplysin | Inhibitor | / | Unkown |
| HY-131508 | M&B 5124 | Inhibitor | / | Unkown |
| HY-131954 | 5-HT3 antagonist 4 | Antagonist | / | Unkown |
| HY-133533 | O-2050 | Antagonist | / | Unkown |
| HY-134191 | Cryptochrome modulator 1 | Modulator | / | Unkown |
| HY-138842 | DDN | Activator | / | Unkown |
| HY-143312C | (S)-V-0219 | Modulator | / | Unkown |
| HY-144668 | RdRP-IN-4 | Inhibitor | / | Unkown |
| HY-146001 | Influenza virus-IN-4 | Inhibitor | / | Unkown |
| HY-146151 | γ-Secretase modulator 12 | / | Unkown | |
| HY-146280 | mGAT3/4-IN-1 | Inhibitor | / | Unkown |
| HY-146293 | HDAC6/HSP90-IN-1 | Inhibitor | / | Unkown |
| HY-146297 | Xanthine oxidoreductase-IN-2 | Inhibitor | / | Unkown |
| HY-146401 | CXCR4 antagonist 6 | Antagonist | / | Unkown |
| HY-146435 | Anti-inflammatory agent 22 | Inhibitor | / | Unkown |
| HY-146458 | Antibacterial agent 102 | Inhibitor | / | Unkown |
| HY-146495 | Antitubercular agent-19 | Inhibitor | / | Unkown |
| HY-146496 | Antitubercular agent-20 | Inhibitor | / | Unkown |
| HY-146505 | Tubulin polymerization-IN-6 | / | Unkown | |
| HY-147335 | 6,9,12,15-Hexadecatetraenoic acid-ethyl ester | / | Unkown | |
| HY-147529 | mGluR2 modulator 3 | Modulator | / | Unkown |
| HY-147678 | GPR40 agonist 5 | Agonist | / | Unkown |
| HY-147692 | COX-2-IN-14 | Inhibitor | / | Unkown |
| HY-148038 | 5-HT3 antagonist 5 | Antagonist | 99.75% | Unkown |
| HY-148617 | ALDH2 modulator 1 | Modulator | / | Unkown |
| HY-149227 | IDO1-IN-21 | Inhibitor | / | Unkown |
| HY-149240 | Anticancer agent 108 | Inhibitor | / | Unkown |
| HY-149298 | PSMA-IN-2 | Inhibitor | / | Unkown |
| HY-149333 | BO-1 | Inhibitor | / | Unkown |
| HY-149521 | PI3K-IN-47 | Inhibitor | / | Unkown |
| HY-149776 | RGH-560 | / | Unkown | |
| HY-149940 | SIMR3030 | Inhibitor | / | Unkown |
| HY-149975 | AMPA receptor modulator-4 | Activator | / | Unkown |
| HY-150036 | Anthramycin | Antagonist | / | Unkown |
| HY-15041 | NVP-SAA164 | Antagonist | / | Unkown |
| HY-151153 | HDAC1-IN-5 | / | Unkown | |
| HY-155229 | CBP/p300-IN-21 | Inhibitor | / | Unkown |
| HY-155236 | Ancistrotecine B | Inhibitor | / | Unkown |
| HY-155328 | GK444 | Inhibitor | / | Unkown |
| HY-155329 | GK718 | Inhibitor | / | Unkown |
| HY-155529 | FD1024 | Inhibitor | / | Unkown |
| HY-155548 | RORγt inverse agonist 31 | Inhibitor | / | Unkown |
| HY-155652 | ABCG2-IN-1 | Inhibitor | / | Unkown |
| HY-155682 | Antibacterial agent 150 | Inhibitor | / | Unkown |
| HY-156792 | RIOK2-IN-1 | Inhibitor | / | Unkown |
| HY-157085 | BX-2819 | Inhibitor | / | Unkown |
| HY-157211 | Anti-inflammatory agent 66 | Inhibitor | / | Unkown |
| HY-157326 | hMAO-B-IN-6 | Inhibitor | / | Unkown |
| HY-157429 | 25N-N1-Nap | Agonist | / | Unkown |
| HY-157430 | BET-IN-21 | Inhibitor | / | Unkown |
| HY-158006 | SDX-7539 | Inhibitor | / | Unkown |
| HY-158272 | Penicillin/OVA | Inhibitor | / | Unkown |
| HY-158434 | IRAK1-IN-1 | Inhibitor | / | Unkown |
| HY-158649 | Fasnall benzenesulfonate | / | Unkown | |
| HY-159602 | BET BD2-IN-3 | Inhibitor | / | Unkown |
| HY-159891 | Microtubule destabilizing agent-2 | / | Unkown | |
| HY-159895 | PAR4 antagonist 7 | Antagonist | / | Unkown |
| HY-159941 | tau-0N4R-IN-1 | Inhibitor | / | Unkown |
| HY-159942 | 5-HT7R antagonist 3 | / | Unkown | |
| HY-160025 | IDO antagonist-1 | Antagonist | / | Unkown |
| HY-161281 | α-Glucosidase-IN-49 | Inhibitor | / | Unkown |
| HY-161372 | PARP1/c-Met-IN-1 | / | Unkown | |
| HY-161373 | PI3Kα-IN-22 | Inhibitor | / | Unkown |
| HY-161458 | GSK-3β inhibitor 16 | / | Unkown | |
| HY-161860 | Antibacterial agent 233 | Inhibitor | / | Unkown |
| HY-161863 | Tubulin polymerization-IN-67 | / | Unkown | |
| HY-161887 | SMARCA2-IN-8 | Inhibitor | / | Unkown |
| HY-161890 | Antimycobacterial agent-8 | Inhibitor | / | Unkown |
| HY-161893 | Anti-MRSA agent 15 | Inhibitor | / | Unkown |
| HY-162406 | UNC8969 | / | Unkown | |
| HY-162655A | SLF80821178 hydrochloride | Inhibitor | / | Unkown |
| HY-162703 | Lipid-lowering agent-2 | Activator | / | Unkown |
| HY-162727 | GCS-12 | / | Unkown | |
| HY-162751 | Anticancer agent 249 | / | Unkown | |
| HY-162760 | COMT-IN-1 | Inhibitor | / | Unkown |
| HY-162867 | Photosensitizer-5 | Inducer | / | Unkown |
| HY-162879 | FAK inhibitor 7 | / | Unkown | |
| HY-162893 | SX29 | Inhibitor | / | Unkown |
| HY-163003 | Antitrypanosomal agent 19 | Inhibitor | / | Unkown |
| HY-163066 | α-Glucosidase-IN-44 | Inhibitor | / | Unkown |
| HY-163300 | NLRP3-IN-30 | Inhibitor | / | Unkown |
| HY-163320 | AChE/Aβ-IN-5 | Inhibitor | / | Unkown |
| HY-163363 | β-AR antagonist 2 | Antagonist | / | Unkown |
| HY-163482 | ELQ-596 | Inhibitor | / | Unkown |
| HY-163484 | ELQ-650 | Inhibitor | / | Unkown |
| HY-163651 | (R)-Vorbipiprant | Antagonist | / | Unkown |
| HY-163797 | WRN inhibitor 10 | Inhibitor | / | Unkown |
| HY-163799 | PRMT5-MTA-IN-1 | Inhibitor | / | Unkown |
| HY-163816 | Antiproliferative agent-53-d3 | Inhibitor | / | Unkown |
| HY-163817 | PARP1/2-IN-3 | Inhibitor | / | Unkown |
| HY-163906 | Anti-MRSA agent 16 | Inhibitor | / | Unkown |
| HY-163978 | YGZ-331 | Activator | / | Unkown |
| HY-165425 | KR31173 | Antagonist | / | Unkown |
| HY-168021 | MAO-A/SERT-IN-1 | Inhibitor | / | Unkown |
| HY-168031 | AChE/BChE-IN-21 | / | Unkown | |
| HY-168444 | CDK4/6-IN-23 | Inhibitor | / | Unkown |
| HY-168742 | V1a/V2 antagonist 1 | Antagonist | / | Unkown |
| HY-169007 | STAT3-IN-34 | Inhibitor | / | Unkown |
| HY-169019 | XJTU-L453 | / | Unkown | |
| HY-169037 | Δ8-Tetrahydrocannabinoquinone | Inducer | / | Unkown |
| HY-169104 | InhA-IN-8 | Inhibitor | / | Unkown |
| HY-169394 | 5-HT1AR agonist 2 | / | Unkown | |
| HY-169928 | WRN inhibitor 14 | Inhibitor | / | Unkown |
| HY-170659 | NF-κB-IN-18 | Inhibitor | / | Unkown |
| HY-170934 | BW710 | Inhibitor | / | Unkown |
| HY-170977 | JAK1/STAT3-IN-1 | Inhibitor | / | Unkown |
| HY-171035 | PRL-295 | Inhibitor | / | Unkown |
| HY-171732 | FANFT | / | Unkown | |
| HY-172456 | JSF-4898 | Inhibitor | / | Unkown |
| HY-172674 | HPK1-IN-59 | Inhibitor | / | Unkown |
| HY-172732 | PRMT5-IN-50 | Inhibitor | / | Unkown |
| HY-172781 | HDAC6-IN-55 | Inhibitor | / | Unkown |
| HY-173316 | STING-IN-12 | Inhibitor | / | Unkown |
| HY-173347 | BLINK11 | Inhibitor | / | Unkown |
| HY-173348 | BLINK15 | Inhibitor | / | Unkown |
| HY-173471 | TRPA1 agonist-1 | Agonist | / | Unkown |
| HY-173479 | GLP-1R agonist 30 | Agonist | / | Unkown |
| HY-173518 | SIN 14 | / | Unkown | |
| HY-175042 | D-myo-Inositol-1,3,4,5,6-pentaphosphate ammonium salt | Inhibitor | 98% | Unkown |
| HY-176052 | PPO-allene | Inhibitor | / | Unkown |
| HY-176063 | TRPV1 antagonist 11 | / | Unkown | |
| HY-176127 | JX10 | Inhibitor | / | Unkown |
| HY-176288 | eIF4E/eIF4G PPI-IN-1 | / | Unkown | |
| HY-176775 | TPP-IOA | Inhibitor | / | Unkown |
| HY-179379 | EP4 receptor agonist 3 prodrug | / | Unkown | |
| HY-179463 | BKI 1708 | Inhibitor | / | Unkown |
| HY-180291 | Anti-inflammatory agent 109 | Inhibitor | / | Unkown |
| HY-180785 | G243-1720 | Inhibitor | / | Unkown |
| HY-180829 | HDAC6-IN-71 | Inhibitor | / | Unkown |
| HY-182418 | UR-11353 | / | Unkown | |
| HY-183340 | Antibacterial agent 341 | / | Unkown | |
| HY-40156A | Mycobacterium Tuberculosis-IN-5 | Inhibitor | / | Unkown |
| HY-B0693S | Ranitidine-d6 | / | Unkown | |
| HY-B1002S | Oxolinic acid-d5 | Inhibitor | 98.0% | Unkown |
| HY-B2046S | Simazine-d10 | / | Unkown | |
| HY-B2185 | Tipepidine citrate | / | Unkown | |
| HY-D1066 | NIR-Thiol dinitrobenzenesulfonate | / | Unkown | |
| HY-D1535 | IR 813 perchlorate | / | Unkown | |
| HY-D2095 | Medical fluorophore 33 | / | Unkown | |
| HY-D2988 | BIN-3 | / | Unkown | |
| HY-N0219R | Bicuculline (Standard) | Antagonist | / | Unkown |
| HY-N10312 | Yadanzigan | Inhibitor | / | Unkown |
| HY-N10341 | Centaureidin | Activator | / | Unkown |
| HY-N11021 | Feruloyl tyramine | / | Unkown | |
| HY-N11723 | Catenarin | Inhibitor | / | Unkown |
| HY-N11730 | 6',7'-Epoxyrotenone | / | Unkown | |
| HY-N12042 | Taxamairin B | Inhibitor | / | Unkown |
| HY-N12249 | 7-Deoxy-trans-dihydronarciclasine | Inhibitor | / | Unkown |
| HY-N15177 | Δ9-THCB | Agonist | / | Unkown |
| HY-N15703 | Norisocorydine | / | Unkown | |
| HY-N18124 | 1-O-Tigloyl-1-O-debenzoylohchinal | / | Unkown | |
| HY-N5126 | Juncusol | / | Unkown | |
| HY-N7047 | 8-Epidiosbulbin E acetate | Inhibitor | 98.42% | Unkown |
| HY-N7271R | Solanidine (Standard) | / | Unkown | |
| HY-N7944 | Eucommiol | / | Unkown | |
| HY-N9475 | Betulonaldehyde | Inhibitor | / | Unkown |
| HY-P10029 | Sakura-6 | Inhibitor | / | Unkown |
| HY-P10057 | cpm-1285 | Inducer | / | Unkown |
| HY-P10110 | retro-inverso TAT-Beclin 1 (D-amino acid) | Inducer | / | Unkown |
| HY-P10721 | Plectasin | Inhibitor | / | Unkown |
| HY-P11405 | [D-Arg1,D-Trp5,7,9,Leu11]-Substance P | Antagonist | / | Unkown |
| HY-P11431 | Cyclo(Gly-Pro) | / | Unkown | |
| HY-P11467 | Gy-CATH | / | Unkown | |
| HY-P1259 | PR-39 | Inhibitor | / | Unkown |
| HY-P1302A | Orphanin FQ(1-11) TFA | Agonist | / | Unkown |
| HY-P1949 | Cyclic MKEY | / | Unkown | |
| HY-P3102A | GLP-1(32-36)amide TFA | / | Unkown | |
| HY-P3707 | Tumor targeted pro-apoptotic peptide | Inducer | / | Unkown |
| HY-P5130 | Big endothelin-1 (rat 1-39) | Ligand | / | Unkown |
| HY-P5890 | YVAD-CHO | Inhibitor | / | Unkown |
| HY-RS08425 | MICAL1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W004681 | 5-Hydroxy-2-methylpyridine | 99.97% | Unkown | |
| HY-W040276 | Diafen NN | / | Unkown | |
| HY-W097106 | (S)-3-N-Cbz-Amino-succinimide | 97.0% | Unkown | |
| HY-W1142093 | ActRIIB-IN-4 | / | Unkown | |
| HY-W331017 | 1-Hexacosanoyl-sn-glycero-3-phosphocholine | / | Unkown | |
| HY-W744266 | 9α,10α-Epoxyhexahydrocannabinol | / | Unkown | |
| HY-W795264 | FR900098 | Inhibitor | / | Unkown |
| HY-100442S | Paquinimod-d5 | Inhibitor | / | Unkown |
| HY-100840 | (S)-4C3HPG | / | Unkown | |
| HY-101699A | AMG-076 | Antagonist | / | Unkown |
| HY-101775 | 9-Hydroxyellipticin | Inhibitor | / | Unkown |
| HY-103163 | (±)-5'-Chloro-5'-deoxy-ENBA | Agonist | / | Unkown |
| HY-103388 | NCX 466 | Inhibitor | / | Unkown |
| HY-103567A | Desmethyl-YM-298198 | Antagonist | / | Unkown |
| HY-109044S | Tapinarof-d5 | Agonist | / | Unkown |
| HY-116799 | NSC 145669 | Inhibitor | / | Unkown |
| HY-117446 | AS-1669058 | Agonist | / | Unkown |
| HY-118537 | ICI 56780 | Inhibitor | / | Unkown |
| HY-118802 | 4-Hydroxy DPT | / | Unkown | |
| HY-118803 | AS1468240 | Inhibitor | / | Unkown |
| HY-119218 | LH 1 | / | Unkown | |
| HY-119955 | Amflutizole | Inhibitor | / | Unkown |
| HY-120450 | CL-55 | Inhibitor | / | Unkown |
| HY-120462 | Genz-669178 | Inhibitor | / | Unkown |
| HY-124290A | Carotegrast methyl hydrochloride | Antagonist | / | Unkown |
| HY-124499 | RUC-1 | Inhibitor | / | Unkown |
| HY-12580 | RO5353 | MDM2 Inhibitor | / | Unkown |
| HY-12610 | Carbonic anhydrase inhibitor 27 | Inhibitor | / | Unkown |
| HY-126170 | Valanimycin | Inhibitor | / | Unkown |
| HY-127014 | Julimycin B2 | Inhibitor | / | Unkown |
| HY-129318 | MBX-1066 | Inhibitor | / | Unkown |
| HY-129347 | Lankacyclinol A | Inhibitor | / | Unkown |
| HY-134314 | 8-Nitro-cGMP | Inducer | / | Unkown |
| HY-134579 | Chaetomellic acid A | Inhibitor | / | Unkown |
| HY-138100 | Hyalodendrin | Inhibitor | / | Unkown |
| HY-138291 | Ethoxyquin dimer | 98.70% | Unkown | |
| HY-139240 | Cannabidihexol | / | Unkown | |
| HY-147548 | Keap1-Nrf2-IN-10 | Inhibitor | / | Unkown |
| HY-161728 | Antibacterial agent 223 | Inhibitor | / | Unkown |
| HY-161935 | 6-(12-Tridecene-1-yl)-2,4-Dihydroxy benzoic acid | Inhibitor | / | Unkown |
| HY-161937 | Antibacterial agent 236 | Inhibitor | / | Unkown |
| HY-164384 | DFX117 | / | Unkown | |
| HY-164462 | BHA536 | / | Unkown | |
| HY-164547 | WHN-88 | Inhibitor | / | Unkown |
| HY-168355 | Δ8-THC methyl ether | Ligand | / | Unkown |
| HY-168365 | (±)-Pellotine hydrochloride | / | Unkown | |
| HY-168368 | exo-Tetrahydrocannabivarin | Ligand | / | Unkown |
| HY-168629 | FXR agonist 9 | Inhibitor | / | Unkown |
| HY-168792 | (±)-9-Nor-9α-hydroxy Hexahydrocannabinol | / | Unkown | |
| HY-170717 | 3-Methylnordiazepam | / | Unkown | |
| HY-172335 | C9-200 | / | Unkown | |
| HY-180129 | SARS-CoV-2-IN-120 | Inhibitor | / | Unkown |
| HY-180360 | Antiparasitic agent-34 | Inhibitor | / | Unkown |
| HY-180936 | FBPase-IN-6 | / | Unkown | |
| HY-21193R | Perfluoropentanoic acid (Standard) | / | Unkown | |
| HY-B0448S2 | Phenytoin-d5 | Inhibitor | / | Unkown |
| HY-N12171 | Isoreserpiline | Inhibitor | / | Unkown |
| HY-N12719 | Isocampneoside I | / | Unkown | |
| HY-N13715 | Thalicminine | / | Unkown | |
| HY-N13894 | Auramycin A | Inhibitor | / | Unkown |
| HY-N13895 | Auramycin B | Inhibitor | / | Unkown |
| HY-N14018 | Glidobactin A | Inhibitor | / | Unkown |
| HY-N14193 | Estatin B | Inhibitor | / | Unkown |
| HY-N14200 | Maridomycin II | Inhibitor | / | Unkown |
| HY-N14201 | Maridomycin IV | Inhibitor | / | Unkown |
| HY-N14202 | Maridomycin V | Inhibitor | / | Unkown |
| HY-N14203 | Maridomycin VI | Inhibitor | / | Unkown |
| HY-N14586 | Roridin J | / | Unkown | |
| HY-N14941 | Phleomycin G | Inhibitor | / | Unkown |
| HY-N15180 | Corynantheidine | / | Unkown | |
| HY-N4031 | Humantenine | Chemical | 98% | Unkown |
| HY-N4243 | Neocurdione | / | Unkown | |
| HY-P0009S1 | Cetrorelix-d10 | Antagonist | / | Unkown |
| HY-P10200 | CP7-FP13-2 | Inhibitor | / | Unkown |
| HY-P4885 | Glp-amyloid-β (3-40) peptide (human) | / | Unkown | |
| HY-W188178 | N-Mitrososarcosine | / | Unkown | |
| HY-W369099 | HJC0152 free base | / | Unkown | |
| HY-W658325 | P-Decyloxyaniline | / | Unkown | |
| HY-W665796 | N-Methyl-N-nitroso-2-propanamine | / | Unkown | |
| HY-W681659 | Flutoprazepam | Inhibitor | / | Unkown |
| HY-109506S10 | DPPC-13C3 | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(8)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99123 | Anti-Mouse CD28 Antibody (37.51) | 95.00% | Unkown | |
| HY-P99148 | Anti-Mouse/Rat/Rabbit TNF alpha Antibody (TN3-19.12) | Inhibitor | 99.24% | Unkown |
| HY-P99129 | Anti-Mouse CD8a Antibody (53-6.7) | Inhibitor | 98.18% | Unkown |
| HY-P990282 | Anti-Mouse CD24 Antibody (M1/69) | Inhibitor | ≥95.0% | Unkown |
| HY-P99620 | Firivumab | Inhibitor | 95.00% | Unkown |
| HY-P990812 | Anti-Mouse myeloperoxidase/MPO Antibody (6D1) | Inhibitor | 98.82% | Unkown |
| HY-P991433 | BIIB036 | Activator | / | Unkown |
| HY-P992059 | Anti-Mouse CD1d Antibody (1B1) | Antagonist | / | Unkown |